Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses

Title
Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses
Authors
Keywords
-
Journal
STROKE
Volume 45, Issue 8, Pages 2354-2358
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-07-11
DOI
10.1161/strokeaha.114.005989

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started